Skip to content
  • Wednesday, 8 July 2026
  • 10:48 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • NVIDIA Unveils BioNeMo Agent Toolkit to Accelerate Life Sciences R&D with AI
Pharmaceutical R&D

NVIDIA Unveils BioNeMo Agent Toolkit to Accelerate Life Sciences R&D with AI

Teuku Ryan Jun 24, 2026 0

San Diego, CA – NVIDIA has officially launched the BioNeMo agent toolkit, a groundbreaking suite of tools specifically engineered to…

Read More
Pharmaceutical R&D

QIAGEN Digital Insights Partners with NVIDIA to Revolutionize AI-Driven Drug Discovery

Teuku Ryan May 20, 2026 0

The integration of NVIDIA’s accelerated computing and BioNeMo platform with QIAGEN Digital Insights’ bioinformatics capabilities is poised to usher in…

Read More
TWiV 1285: Encapsidating Viruses 2025Scientists from The University of Manchester Identify New Subatomic Particle Xi-cc-plus at CERNs Large Hadron ColliderClimate change may make hail more destructive in some regions while easing risks in othersMerck KGaA Acquires JSR Life Sciences’ Chromatography Business to Bolster Biopharmaceutical Purification Capabilities
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information Stability
Discovery of Fam102a Protein as a Dual Regulator of Bone Remodeling Offers New Pathways for Osteoporosis TreatmentWorld-first gene editing application unveils master regulator of human embryo developmentInsuring the Trip: An Underwriter on What It Will Take for Approved Psilocybin to Become a Real BusinessFat-Engorged Immune Cells Identified as Key Drivers of Rapid Disease Progression in Multiple Sclerosis Patients
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
Discovery of Fam102a Protein as a Dual Regulator of Bone Remodeling Offers New Pathways for Osteoporosis Treatment
Dwi Wanna Jul 8, 2026
Biotech & Genetic Research
World-first gene editing application unveils master regulator of human embryo development
Jia Lissa Jul 8, 2026
Laboratory Automation & Robotics
Insuring the Trip: An Underwriter on What It Will Take for Approved Psilocybin to Become a Real Business
Lana Keisha Jul 8, 2026
Neuroscience & Brain Research
Fat-Engorged Immune Cells Identified as Key Drivers of Rapid Disease Progression in Multiple Sclerosis Patients
Rifan Muazin Jul 8, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ